Big thanks to CompPAC investors
CompPAC is the way APC supports members of Congress who think like you do about pharmacy compounding. And where does CompPAC get its funding? From compounders like you.
CompPAC is the way APC supports members of Congress who think like you do about pharmacy compounding. And where does CompPAC get its funding? From compounders like you.
APC staff has prepared a comparison document illuminating the differences between the new USP Chapter <797> on sterile compounding that takes effect November 1 and proposed regulation from the California Board of Pharmacy.
Five U.S. Senators have written to the FDA urging that the agency assure continued patient access to compounded hormones for patients.
Last Friday, the FDA announced that it has updated the list of bulk drug substances nominated for use under section 503A.
Introducing a new benefit for our Pharmacy/Facility Members.
Take our survey to help us provide some clarity on the state of the compounding profession.
You can cast your ballot for APC's 2024 Board of Directors starting on October 6.
An important survey is coming soon to an email inbox near you.
APC’s CCH 2023 wrapped up Wednesday, having added a half dozen new sponsors to its drug shortage legislation in the House and cultivated serious interest in the bill language from a handful of Senate offices.
Iowa pharmacist Sue Horton received APC’s George & Lucy Malmberg Advocacy Champion Award this week during Compounders on Capitol Hill.